Prelude Capital Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-900
Closed -$3K 1834
2017
Q3
$3K Buy
+900
New +$3K ﹤0.01% 1418
2017
Q2
Sell
-23,400
Closed -$98K 1978
2017
Q1
$98K Buy
23,400
+22,100
+1,700% +$92.6K 0.01% 743
2016
Q4
$5K Sell
1,300
-1,190
-48% -$4.58K ﹤0.01% 1397
2016
Q3
$9K Buy
2,490
+1,910
+329% +$6.9K ﹤0.01% 1375
2016
Q2
$2K Buy
+580
New +$2K ﹤0.01% 1465
2015
Q4
Sell
-2,850
Closed -$42K 1844
2015
Q3
$42K Sell
2,850
-5,000
-64% -$73.7K 0.01% 1023
2015
Q2
$153K Buy
+7,850
New +$153K 0.02% 685